Every record from Medutest · page 18
Fast turnaround and the widest compound acceptance, at unit mass resolution rather than high resolution. Measured offset against the reference laboratory is +0.065 pp on 517 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020785 | PT-141 (Bremelanotide) | SGN | SGN-2412-Y9700 | 2025-Q1 | 98.32 | 6.35 | 90.3 | Supplier-supplied | 2 | FAIL |
| AX-2025-021173 | BPC-157 | WXT | WXT-2412-Y6192 | 2025-Q1 | 99.93 | 7.81 | 99.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018849 | BPC-157 | QSC | QSC-2412-D8748 | 2025-Q1 | 99.93 | 5.83 | 106.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019704 | Tirzepatide | HJ | HJ-2501-P2892 | 2025-Q1 | 97.53 | 2.16 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020542 | MOTS-c | SSA | SSA-2501-M6043 | 2025-Q1 | 97.77 | 2.19 | 94.0 | Supplier-supplied | 0 | FAIL |
| AX-2025-018952 | CJC-1295 (no DAC) | FGP | FGP-2503-P1477 | 2025-Q1 | 98.97 | 6.94 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-019903 | P21 | SWB | SWB-2408-T5745 | 2025-Q1 | 98.88 | 8.08 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019286 | Dihexa | TFC | TFC-2409-U6527 | 2025-Q1 | 99.30 | 7.09 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019815 | Retatrutide | HJ | HJ-2411-D4299 | 2025-Q1 | 99.84 | 5.20 | 107.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019262 | GHRP-2 | TFC | TFC-2502-D6597 | 2025-Q1 | 99.70 | 4.88 | 93.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019127 | Tirzepatide | JEEP | JEEP-2412-N4458 | 2025-Q1 | 99.61 | 5.50 | 106.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018853 | Liraglutide | QSC | QSC-2502-M9247 | 2025-Q1 | 99.19 | 3.88 | 96.4 | Supplier-supplied | 1 | FAIL |
| AX-2025-018767 | TB-500 | QSC | QSC-2411-X7470 | 2025-Q1 | 99.93 | 5.45 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020812 | Semaglutide | SGN | SGN-2410-D9857 | 2025-Q1 | 97.86 | 4.64 | 98.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020655 | L-Glutathione (reduced) | SSA | SSA-2501-W8087 | 2025-Q1 | 98.57 | 10.25 | 100.1 | Supplier-supplied | 0 | PASS |
| AX-2025-019246 | TB-500 | TFC | TFC-2412-A6202 | 2025-Q1 | 99.93 | 3.60 | 101.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020460 | Liraglutide | KP | KP-2502-E5076 | 2025-Q1 | 99.46 | 6.08 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020701 | Tirzepatide | GL Biochem | GLBI-2412-R8816 | 2025-Q1 | 99.48 | 4.35 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020482 | Sermorelin | KP | KP-2501-V5157 | 2025-Q1 | 98.01 | 5.61 | 96.8 | Buyer-sourced | 0 | PASS |
| AX-2025-020242 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2502-H2314 | 2025-Q1 | 98.53 | 4.40 | 99.8 | Supplier-supplied | 2 | FAIL |
| AX-2025-019818 | Retatrutide | HJ | HJ-2411-D4299 | 2025-Q1 | 98.88 | 5.74 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-019241 | TB-500 | TFC | TFC-2412-A6202 | 2025-Q1 | 99.56 | 2.59 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2025-018436 | Semaglutide | WWB | WWB-2501-Y2776 | 2025-Q1 | 99.05 | 4.52 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-019850 | AOD-9604 | SWB | SWB-2502-N4413 | 2025-Q1 | 99.18 | 5.44 | 100.2 | Buyer-sourced | 0 | PASS |
| AX-2025-019232 | Semaglutide | TFC | TFC-2502-L6365 | 2025-Q1 | 97.87 | 3.36 | 104.1 | Supplier-supplied | 0 | PASS |
| AX-2025-018723 | Tirzepatide | QSC | QSC-2408-T6517 | 2025-Q1 | 99.73 | 5.47 | 99.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018536 | MK-677 (Ibutamoren mesylate) | WWB | WWB-2411-X3830 | 2025-Q1 | 99.61 | 2.79 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020107 | Semaglutide | GGPeps | GGPE-2501-W9136 | 2025-Q1 | 99.33 | 5.45 | 107.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019996 | Follistatin-344 | ERP | ERP-2411-Y6431 | 2025-Q1 | N/A | 2.97 | — | Supplier-supplied | 1 | N/A |
| AX-2025-018563 | Retatrutide | WWB | WWB-2412-N4087 | 2025-Q1 | 99.17 | 3.74 | 101.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021166 | BPC-157 | WXT | WXT-2412-Y6192 | 2025-Q1 | 99.54 | 8.16 | 89.0 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-021163 | BPC-157 | WXT | WXT-2412-Y6192 | 2025-Q1 | 99.37 | 7.83 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-018945 | BPC-157 | FGP | FGP-2409-Y1557 | 2025-Q1 | 99.48 | 4.79 | 90.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018911 | Retatrutide | FGP | FGP-2501-S9984 | 2025-Q1 | 98.68 | 4.62 | 93.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020199 | CJC-1295 (no DAC) | GGPeps | GGPE-2408-G9786 | 2025-Q1 | 98.27 | 3.13 | 94.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018432 | Tirzepatide | WWB | WWB-2411-A2303 | 2025-Q1 | 99.41 | 2.11 | 102.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018511 | Semaglutide | WWB | WWB-2501-K3141 | 2025-Q1 | 98.85 | 4.28 | 95.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020108 | Semaglutide | GGPeps | GGPE-2501-W9136 | 2025-Q1 | 98.25 | 6.04 | 97.8 | Supplier-supplied | 1 | FAIL |
| AX-2025-019553 | KPV | Homopeptide | HOMO-2411-P1141 | 2025-Q1 | 99.64 | 5.43 | 103.7 | Supplier-supplied | 0 | FAIL |
| AX-2025-019688 | IGF-1 LR3 | HJ | HJ-2410-G2561 | 2025-Q1 | 98.07 | 2.85 | 92.4 | Supplier-supplied | 0 | PASS |